Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for aortic remodeling in bicuspid aortic valve
2010-018880-41Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of losartan in bicuspid aortic valve (BAV) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Aortic root and ascending aorta dilatation, Reduced aortic compliance prevalence and 6 more. Started May 2010; status: completed.
02
Drugs
losartan
03
Conditions
bicuspid aortic valve (BAV)
Beyond the preview
Go deeper on 2010-018880-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018880-41.